Return to homepagePandemic Pact

CK2 inhibitors as chemobiological tools to decode the role of CK2 in the SARS-COV-2 life cycle and as broad-spectrum anti-coronavirus therapies

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    ANR

  • Principal Investigator

    Isabelle Krimm

  • Research Location

    France

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract